Anti-doping agency says UEFA followed the rules in Ramos case

Image
IANS Madrid
Last Updated : Nov 24 2018 | 2:15 PM IST

The World Anti-Doping Agency (WADA) has confirmed that UEFA acted properly in a case involving the possible use of a banned substance by Real Madrid captain Sergio Ramos ahead of the 2017 Champions League final.

UEFA complied with the relevant directives, WADA said in a letter.

The matter had became public on Friday after German newsweekly Der Spiegel ran a report from Football Leaks contending that Ramos tested positive for dexamethasome following Real Madrid's victory over Juventus in the Champions League final, reports Efe news.

Dexamethasome, an anti-inflammatory, is permitted if the player gives notice before testing. In this case, according to Football Leaks, the UEFA testers were advised that Ramos, 32, had taken a different drug.

UEFA accepted the explanation from Ramos and the club that the team's doctor made a mistake.

Der Spiegel's story also maintained that "no disciplinary action was taken, neither against the player nor against the team doctor from Real Madrid, despite all of the anomalies in the case."

Real Madrid reacted to the story within hours.

"Sergio Ramos has never breached anti-doping regulations," the club said in a brief statement, adding that UEFA "immediately closed the case referred to, as is customary in such instances, following tests carried out by experts from the World Anti-Doping Association and UEFA itself."

UEFA likewise rejected accusations of misconduct.

"All UEFA doping control cases are conducted in full compliance with the World Anti-Doping Agency Code," Europe's soccer confederation said in a statement.

"WADA itself has officially confirmed that everything was dealt with appropriately by UEFA and in accordance with the Code," the statement said.

--IANS

kk/bg

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Nov 24 2018 | 2:08 PM IST

Next Story